Bioengineering platforms such as hydrogels, decellularized scaffolds, and extracellular vesicles provide architectural, trophic, and immunomodulatory support.
First-pass extracted concept
bioengineering platforms for skeletal muscle atrophy
Candidate: concept label1 source documents3 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
decellularized scaffolds, extracellular vesicles, hydrogels
Evidence Snippets
Supporting Sources
Linked Claims
Neuromuscular junction destabilization, excitation-contraction coupling defects, and mitochondrial dysfunction intensify calcium dysregulation and promote reactive oxygen and nitrogen species accumulation in skeletal muscle atrophy.
Quoted textsource-backed
Skeletal muscle atrophy emerges from intertwined neuromuscular and metabolic failures, in which neuromuscular junction destabilization, excitation contraction coupling defects, and mitochondrial dysfunction collectively intensify calcium dysregulation and drive the accumulation of reactive oxygen and nitrogen species (RONS)
Hydrogels, decellularized scaffolds, and extracellular vesicles can provide architectural, trophic, and immunomodulatory support in therapeutic strategies for skeletal muscle atrophy.
Quoted textsource-backed
Bioengineering platforms such as hydrogels, decellularized scaffolds, and extracellular vesicles provide architectural, trophic, and immunomodulatory support.
Translational progress in skeletal muscle atrophy therapy requires rigorous safety pipelines, mechanistic biomarkers of motor unit recovery, and modular combination regimens integrating cells, genes, scaffolds, and rehabilitative input.
Quoted textsource-backed
Translational progress requires rigorous safety pipelines, mechanistic biomarkers of motor unit recovery, and modular combination regimens that integrate cells, genes, scaffolds, and rehabilitative input.